An international pharmaceutical company Merck has developed a capsule to protect against the coronavirus and its associated disease, Covid 19, which can reduce the severity of the disease and reduce hospital admissions and mortality rates.
In Phase Two Clinical Trial, the capsule was successfully tested in 775 volunteers from the US and other countries who were infected with the coronavirus. All volunteers were given the capsule twice a day, for five consecutive days. None of the volunteers who used it reached the hospital or died of the coronavirus.
Merck says it has the first antiviral pill found to be effective against Covid. The capsule is also effective against the delta variant of the coronavirus, which is currently the leading cause of the Covid 19 global epidemic, according to a Merck & Co. press release.
Merck has also asked the US Food and Drug Administration (FDA) to approve the capsule on an emergency basis.